These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 18588562)
41. Allergen immunotherapy in historical perspective. Cohen SG; Richard E Clin Allergy Immunol; 2008; 21():1-29. PubMed ID: 18828495 [No Abstract] [Full Text] [Related]
42. Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data. Letz AG; Tankersley MS; Dice JP; England RW J Allergy Clin Immunol; 2009 May; 123(5):1175-6. PubMed ID: 19251313 [No Abstract] [Full Text] [Related]
43. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. Akdis CA; Akdis M J Allergy Clin Immunol; 2009 Apr; 123(4):735-46; quiz 747-8. PubMed ID: 19348912 [TBL] [Abstract][Full Text] [Related]
44. Regulatory control and standardization of allergenic extracts. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):177-220. PubMed ID: 3196018 [No Abstract] [Full Text] [Related]
46. [Status of allergen immunotherapy in the treatment of allergic diseases]. Okano M Arerugi; 2006 Jan; 55(1):22-7. PubMed ID: 16671327 [No Abstract] [Full Text] [Related]
47. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens. Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498 [TBL] [Abstract][Full Text] [Related]
48. Allergen immunotherapy: the scientific facts. Gaur SN Indian J Chest Dis Allied Sci; 2011; 53(4):205-6. PubMed ID: 22128617 [No Abstract] [Full Text] [Related]
49. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy. Calabria CW; Coop CA; Tankersley MS J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075 [TBL] [Abstract][Full Text] [Related]
50. Recombinant allergens; basic and practical considerations. Breiteneder H; Hoffmann-Sommergruber K; Vanek-Krebitz M; Kraft D; Scheiner O Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):80-6. PubMed ID: 9383894 [No Abstract] [Full Text] [Related]
51. Specific immunotherapy design questions. Moed H; de Bot C; van der Wouden JC Allergy; 2006 Jul; 61(7):896. PubMed ID: 16792592 [No Abstract] [Full Text] [Related]
52. A century of immunotherapy. Warner JO Pediatr Allergy Immunol; 2008 Nov; 19(7):569-70. PubMed ID: 18950322 [No Abstract] [Full Text] [Related]